Metastatic Breast Cancer
Metastatic breast cancer is a stage of breast cancer where the disease has spread beyond the breast to other parts of the body, often requiring specialized treatment.
Breast Cancer Treatment: Chemotherapy vs. Endocrine Therapy
We are studying the effectiveness of chemotherapy compared to endocrine therapy for women with ER-positive HER2-negative metastatic breast cancer. This trial focuses on patients with specific health markers to determine the best treatment option.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a female aged 18 years or older?
- Do you have metastatic invasive breast cancer (not lobular type)?
- Are you currently pregnant or breastfeeding?
- Have you had any chemotherapy for metastatic breast cancer?
- Have you had any other cancer in the last 3 years?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Institut Bergonie
Medical oncology
Bordeaux, France
Centre Francois Baclesse
Medical oncology
Caen, France
Institut Regional Du Cancer De Montpellier
Medical oncology
Grabels, France
Sponsor: Institut Curie
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.